These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 36116093)
1. Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study. Chitkara A; Mesa-Eguiagaray I; Wild SH; Hall PS; Cameron DA; Sims AH; Figueroa JD Breast Cancer Res Treat; 2022 Nov; 196(2):379-387. PubMed ID: 36116093 [TBL] [Abstract][Full Text] [Related]
2. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999 [TBL] [Abstract][Full Text] [Related]
3. Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China. Wang JM; Wang J; Zhao HG; Liu TT; Wang FY Biomed Res Int; 2020; 2020():5931529. PubMed ID: 32337260 [TBL] [Abstract][Full Text] [Related]
4. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357 [TBL] [Abstract][Full Text] [Related]
5. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466 [TBL] [Abstract][Full Text] [Related]
6. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study. Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840 [TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea. Lee JS; Oh M; ; Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438 [TBL] [Abstract][Full Text] [Related]
9. Association between common risk factors and molecular subtypes in breast cancer patients. Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series. Sengal AT; Haj-Mukhtar NS; Elhaj AM; Bedri S; Kantelhardt EJ; Mohamedani AA BMC Cancer; 2017 Dec; 17(1):804. PubMed ID: 29191181 [TBL] [Abstract][Full Text] [Related]
12. Relationship of established risk factors with breast cancer subtypes. McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510 [TBL] [Abstract][Full Text] [Related]
13. A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States. Sanderson M; Pal T; Beeghly-Fadiel A; Fadden MK; Dujon SA; Clinton C; Jimenez C; Davis J; Fortune M; Thompson J; Benson K; Conley N; Reid S; Tezak A; Shu XO; Zheng W; Blot WJ; Lipworth L Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1416-1423. PubMed ID: 33947654 [TBL] [Abstract][Full Text] [Related]
14. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer. Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery. Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768 [TBL] [Abstract][Full Text] [Related]
16. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Brouckaert O; Rudolph A; Laenen A; Keeman R; Bolla MK; Wang Q; Soubry A; Wildiers H; Andrulis IL; Arndt V; Beckmann MW; Benitez J; Blomqvist C; Bojesen SE; Brauch H; Brennan P; Brenner H; Chenevix-Trench G; Choi JY; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Eriksson M; Fasching PA; Figueroa J; Flyger H; Giles GG; González-Neira A; Guénel P; Hall P; Hollestelle A; Hopper JL; Ito H; Jones M; Kang D; ; Knight JA; Kosma VM; Li J; Lindblom A; Lilyquist J; Lophatananon A; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Muir K; Nevanlinna H; Peterlongo P; Pylkäs K; Saajrang S; Seynaeve C; Shen CY; Shu XO; Southey MC; Swerdlow A; Teo SH; Tollenaar RAEM; Truong T; Tseng CC; van den Broek AJ; van Deurzen CHM; Winqvist R; Wu AH; Yip CH; Yu JC; Zheng W; Milne RL; Pharoah PDP; Easton DF; Schmidt MK; Garcia-Closas M; Chang-Claude J; Lambrechts D; Neven P Breast Cancer Res; 2017 Nov; 19(1):119. PubMed ID: 29116004 [TBL] [Abstract][Full Text] [Related]
17. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744 [TBL] [Abstract][Full Text] [Related]
18. Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway. Hjerkind KV; Johansson ALV; Trewin CB; Russnes HG; Ursin G Breast Cancer Res; 2022 Jan; 24(1):4. PubMed ID: 35012613 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study. Kakudji BK; Mwila PK; Burger JR; du Plessis JM; Naidu K Pan Afr Med J; 2021; 38():85. PubMed ID: 33889251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]